What do you think? With approval in Europe, I can see how a large pharma company with distribution in place can extract synergies, increase distribution and have another product to sell into ER and ambulances.
What will be the reason for them not to take it over?
I only started following MVP recently so please correct me if I am missing anything.
***DYOR***
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.025(3.70%) |
Mkt cap ! $78.86M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 72.5¢ | 67.5¢ | $299.8K | 431.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 311 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| MVP (ASX) Chart |